Medicare billing address
CMS Medicare provider billing file
4403 Harrison BlvdSte 3450
Ogden, UT 84403
CMS public data · NPI 1952569931
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Yonathan Melman, MD/PHD
Specialty
Credential
MD/PHD
NPI
1952569931
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Yonathan Melman, MD/PHD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
4403 Harrison BlvdCMS Doctors & Clinicians file
1380 E Medical Ctr DrCMS Doctors & Clinicians file
1915 W 5950CMS Doctors & Clinicians file
201 W Layton PkwyIn the 2024 CMS provider billing file, this NPI had 748 Medicare beneficiaries and 1,185 total services. The average beneficiary age was 76, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$117,958.25
Total Medicare payment amount
$87,996.07
Medicare beneficiaries
748
Total services
1,185
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
73%
CMS beneficiary-panel share
Atrial fibrillation
60%
CMS beneficiary-panel share
Ischemic heart disease
46%
CMS beneficiary-panel share
Heart failure
43%
CMS beneficiary-panel share
Chronic kidney disease
42%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 177 | $7.59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 150 | $13.30 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 95 | $5.69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 82 | $7.68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 74 | $19.44 |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 68 | $105.64 |
| Programming of dual lead pacemaker system | 60 | $72.33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 50 | $27.75 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 31 | $63.57 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $21.85 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1952569931. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 63 | 123.7 | $71,066.35 |
| 2 | Xarelto | Rivaroxaban | 47 | 93 | $50,338.49 |
| 3 | Pantoprazole Sodium | Pantoprazole Sodium | 38 | 83 | $388.13 |
| 4 | Metoprolol Succinate | Metoprolol Succinate | 23 | 66.7 | $473.92 |
| 5 | Flecainide Acetate | Flecainide Acetate | 15 | 43 | $524.15 |
| 6 | Amiodarone Hcl | Amiodarone Hcl | 13 | 20.7 | $237.49 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Albert Einstein College Of Medicine Of Yeshiva University
Graduation year
2005
Group/practice field
Ihc Health Services Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.